This is not the most recent version of the article. View current version (21 FEB 2014)

Intervention Review

Metal protein attenuating compounds for the treatment of Alzheimer's dementia

  1. Elizabeth L Sampson1,*,
  2. Lydia Jenagaratnam2,
  3. Rupert McShane3

Editorial Group: Cochrane Dementia and Cognitive Improvement Group

Published Online: 16 MAY 2012

Assessed as up-to-date: 9 FEB 2012

DOI: 10.1002/14651858.CD005380.pub4


How to Cite

Sampson EL, Jenagaratnam L, McShane R. Metal protein attenuating compounds for the treatment of Alzheimer's dementia. Cochrane Database of Systematic Reviews 2012, Issue 5. Art. No.: CD005380. DOI: 10.1002/14651858.CD005380.pub4.

Author Information

  1. 1

    University College Medical School, UCL Mental Health Sciences Unit, London, UK

  2. 2

    Churchill Hospital, The Fulbrook Centre, Oxford, UK

  3. 3

    University of Oxford, Nuffield Department of Medicine, Oxford, Oxfordshire, UK

*Elizabeth L Sampson, UCL Mental Health Sciences Unit, University College Medical School, 1st Floor, Charles Bell House,, Riding House Street, London, W1W 7EJ, UK. e.sampson@ucl.ac.uk. e.sampson@medsch.ucl.ac.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 16 MAY 2012

SEARCH

This is not the most recent version of the article. View current version (21 FEB 2014)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Emma L. Cunningham, Anthony P. Passmore, Drug development in dementia, Maturitas, 2013, 76, 3, 260

    CrossRef